MedTrace Logo

Impact of Family Psychoeducation on Psychosis

NCT01172106 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2010-07-29

No results posted yet for this study

Summary

There is currently no clear involvement of families/caregivers in the care for postpartum mothers that develop postpartum psychosis. The lack of knowledge on causes of postpartum psychosis may influence the nature of perceived social support that mothers receive from caregivers. It is hoped that the provision of a culturally adapted version of family psychoeducation will bridge the knowledge gap and provide the much needed information. We therefore hypothesized that the involvement of a family member of a postpartum mother with a psychotic illness in a weekly session of family psychoeducation.

Conditions

  • Postpartum Psychosis

Interventions

BEHAVIORAL

drug compliance

Mothers and their caregivers will be encouraged to comply with the given medication

BEHAVIORAL

Encouragement of drug compliance

Mothers and their caregivers in the placebo comparator will receive an intervention of drug compliance encouragement

BEHAVIORAL

Family psychoeducation

The experimental group will receive family psychoeducation for 12 sessions

Sponsors & Collaborators

  • Swedish International Development Cooperation Agency (SIDA)

    collaborator OTHER_GOV

  • Makerere University

    lead OTHER

Principal Investigators

  • Eija Airaksinen · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2010-09-30
Completion
2010-10-31

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01172106 on ClinicalTrials.gov